Found 48 matching trials
Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
Multiple Locations
Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
NAThis study is being done to determine if sending reminder text messages hel...
Location
Memorial Sloan Kettering Cancer Center
Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer
PHASE2This study evaluate the addition of metformin to standard of care in locall...
Location
Mansoura university
Deciphering Mechanisms Underlying Cancer Immunogenicity
NAThis trial is a translational, open-label, multicentric, prospective cohort...
Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management
NAThe use of oral anticancer agents (OAAs) in cancer treatment has increased ...
Location
Başkent University
The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
PHASE2This is a multicenter, randomized, open-label phase 2/3 study of Toca 511 a...
Location
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
PHASE2Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)
PHASE2The Primary Objective was:
-To determine the antitumor activity of SAR4442...
Location
Thomas Jefferson University Hospital Site Number : 8400009
Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment
N/AOncology management has changed dramatically over the last decade with the ...
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
PHASE2Most patients with metastatic cancer eventually develop resistance to syste...
Location
The 960th Hospital of People's Liberation Army (PLA)